Innate Pharma S.A. (IPHA) Financials
IPHA Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-06-30 | 216.4 million | 153.5 million |
2023-03-31 | 226.6 million | 167.5 million |
2022-12-31 | 213.6 million | 151.5 million |
2022-09-30 | 203.9 million | 150.8 million |
IPHA Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-06-30 | -12.8 million | 761677 |
2023-03-31 | -22.8 million | 900891 |
2022-12-31 | -6.3 million | 751757 |
2022-09-30 | -10.0 million | 810648 |
IPHA Net Income
No data available :(
IPHA Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-06-30 | 96.7 million | - | - |
2023-03-31 | 110.6 million | - | - |
2022-12-31 | 95.4 million | - | 2.2 million |
2022-09-30 | 99.5 million | - | - |
IPHA Shares Outstanding
IPHA Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-06-30 | 339248 | 30.9 million | 4.9 million | 77200 |
2023-03-31 | 765185 | 27.4 million | 5.5 million | 84475 |
2022-12-31 | 165805 | 16.9 million | 4.8 million | 76195 |
2022-09-30 | 56397 | 13.1 million | 5.0 million | 76013 |
IPHA Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-06-30 | 38.4 million | 17.1 million |
2023-03-31 | 9.1 million | 14.6 million |
2022-12-31 | 21.6 million | 16.9 million |
2022-09-30 | 5.9 million | 13.1 million |
IPHA
Price: $2.57
52 week price:
Earnings Per Share: -0.10 USD
P/E Ratio: -3.06
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 6529
Market Capitalization: 205.8 million